A new research document titled, “Global Clinical Trial Management System (CTMS) Market” is released by AdvanceMarketAnalytics. The market study is a cautious attempt of the industry with strategic steps to the targets of business environment and the ones that are tried to have an essential impression on the progression of the Clinical Trial Management System (CTMS) market. AMA recognizes following companies as the major players in the Global Clinical Trial Management System (CTMS) market which includes Oracle Corporation (United States), Medidata Solutions, Inc. (United States), PAREXEL International Corporation (United States), Bioclinica (United States), Bio-Optronics, Inc. (United States), IBM Corporation (United States), MedNet Solutions Inc. (United States), ArisGlobal LLC (United States) and DSG, Inc. (United States).

New technologies and major shifts in the industry will be game-changing factors that all players have to react now in order to maintain strong positions in the future. As many industry experts agree that significant changes are ahead. Increasing Number of Partnerships between Biopharma Companies and Contract Research Organizations (CROs) is one of the key components driving the development of this market in the following couple of years. "Adoption of Platform-as-a-Service (PaaS) and Mobile Computing " adds to the investigation what growth market seeks ahead. This causes analysts to concentrate more on regional factors and regulatory and influencing factors ahead of any other approach.

One of the key patterns that will drive the development prospects for the Clinical Trial Management System (CTMS) amid the anticipated period is the Surged in Number of Outsourcing of Clinical Trial Processes by Industrial Researchers to Asian Countries CROs . The , such as , is boosting the Clinical Trial Management System (CTMS) market. Additionally, the rising demand from SMEs and various industry verticals, macro-economic growth are the prime factors driving the growth of the market.
The Clinical Trial Management System (CTMS) market is very focused because of the nearness of many key organizations. The main Players are focusing on presenting new product/services and are constantly upgrading their existing offerings to keep pace with the overall industry.

The key target audience considered while formulating the study are as follows:
Pharmaceutical/Biopharmaceutical Companies, Healthcare IT Service Providers, Research and Development (R&D) Companies, Clinical Research Organizations, Medical Device Manufacturing Companies, Academic Medical Centres/Universities/Hospitals and Others

Research Methodology:

The top-down and bottom-up approaches are used to estimate and validate the size of the Global Clinical Trial Management System (CTMS) market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Clinical Trial Management System (CTMS) market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Pharmaceutical/Biopharmaceutical Companies, Healthcare IT Service Providers, Research and Development (R&D) Companies, Clinical Research Organizations, Medical Device Manufacturing Companies, Academic Medical Centres/Universities/Hospitals and Others.
This helps us to gather the data for the players’ revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.